
Sacubitril + Valsartan 50 mg | Heart Failure Management | Pharmaceutical Exporter from Nagpur, India
Phoenix Exim is a pharmaceutical exporter based in Nagpur, India, supplying pharmaceutical products for international B2B requirements across markets including USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable regulatory and import requirements.
1. π GENERAL INFORMATION
Sacubrook V 50 mg is a prescription cardiovascular medicine containing the combination of Sacubitril and Valsartan. This combination belongs to the angiotensin receptorβneprilysin inhibitor (ARNI) class and is used as part of appropriate treatment plans for certain patients with chronic heart failure.
The medicine works through two complementary mechanisms: sacubitril enhances beneficial natriuretic peptide activity, while valsartan blocks the effects of angiotensin II. Together, these actions can reduce strain on the heart and support cardiovascular function.
Sacubrook V 50 mg should be taken only according to the prescription and instructions provided by a qualified healthcare professional.
2. π PRODUCT INFORMATION
| Product Detail | Information |
|---|---|
| Brand | Sacubrook V |
| Strength | 50 mg |
| Active Ingredients | Sacubitril + Valsartan |
| Therapeutic Category | Cardiovascular / Heart Failure Medicine |
| Drug Class | ARNI |
| Dosage Form | Tablet |
| Route | Oral |
| Primary Therapeutic Use | Certain forms of chronic heart failure |
| Country of Origin | India |
| Exporter | Phoenix Exim |
| Supply Location | Nagpur, Maharashtra, India |
Note: The exact amount of each active ingredient and the approved indications should be confirmed from the manufacturer's pack insert/product label before commercial or clinical use.
3. π― USES OF SACUBROOK V 50 MG
Sacubitril/valsartan is primarily used as part of a comprehensive treatment plan for certain patients with chronic heart failure.
β€οΈ Heart Failure Management
It can help reduce the workload on the heart and support cardiovascular function in appropriately selected patients.
π Cardiovascular Support
The combination influences hormonal pathways involved in blood-vessel constriction, sodium retention, and cardiac workload.
π₯ Reducing Heart-Failure Events
When appropriately prescribed, sacubitril/valsartan can reduce the risk of hospitalization and cardiovascular events in eligible heart-failure patients.
The exact indication depends on the patient's condition, age, ejection fraction, other medicines, and applicable clinical guidelines.
4. β KEY BENEFITS
When prescribed appropriately, Sacubrook V 50 mg may provide important therapeutic benefits:
β
Supports management of chronic heart failure
β
Helps reduce strain on the heart
β
Promotes vasodilation through its combined mechanism
β
Helps counteract harmful effects of excessive angiotensin-II activity
β
Enhances beneficial natriuretic peptide activity
β
May reduce heart-failure-related hospitalization risk
β
Can support long-term cardiovascular management
β
Combines two complementary mechanisms in one tablet
Important: Sacubrook V 50 mg is not intended to provide an immediate cure for heart failure. Benefits depend on correct diagnosis, appropriate dosing, adherence, and overall medical management.
5. β οΈ SIDE EFFECTS
Like other prescription cardiovascular medicines, Sacubitril/Valsartan can cause side effects.
Possible adverse effects include:
Low blood pressure (hypotension)
Dizziness
Increased potassium levels (hyperkalemia)
Changes in kidney function
Cough
Headache
Fatigue
A potentially serious reaction is angioedema, which may cause swelling of the face, lips, tongue, or throat.
Seek urgent medical attention if significant difficulty breathing or swelling of the face, lips, tongue, or throat occurs.
6. πΉ COMMON SIDE EFFECTS
Possible commonly reported effects include:
Dizziness | Low Blood Pressure | Increased Potassium | Changes in Kidney Function | Cough | Headache | Fatigue
Not everyone experiences these effects. Regular medical monitoring may be recommended, particularly for blood pressure, kidney function, and potassium levels.
7. π HOW TO USE SACUBROOK V 50 MG
Take Sacubrook V 50 mg exactly as prescribed by your healthcare professional.
General Guidance
1οΈβ£ Follow the prescribed dose
Take the medicine according to the schedule provided by your doctor.
2οΈβ£ Take consistently
Try to take it at approximately the same time each day.
3οΈβ£ With or without food
Sacubitril/valsartan may generally be taken with or without food.
4οΈβ£ Swallow properly
Swallow the tablet with water unless your healthcare professional has provided different instructions.
5οΈβ£ Do not double doses
If you miss a dose, follow the missed-dose instructions provided by your doctor or pharmacist rather than taking an extra dose.
β οΈ Important
Do not change the dose or stop treatment without consulting your healthcare professional. Heart-failure treatment often requires long-term management.
8. βοΈ HOW DOES SACUBROOK V 50 MG WORK?
Sacubrook V contains Sacubitril + Valsartan, which work through complementary cardiovascular pathways.
π¬ Sacubitril
Sacubitril is a neprilysin inhibitor. It increases the activity of beneficial natriuretic peptides, which can promote vasodilation and support the body's regulation of sodium and fluid balance.
π‘οΈ Valsartan
Valsartan is an angiotensin II receptor blocker (ARB). It blocks the ATβ receptor, reducing the effects of angiotensin II, including vasoconstriction and processes that can increase cardiovascular workload.
π€ Combined ARNI Action
Together, these mechanisms can:
Reduce harmful neurohormonal activity β Support vasodilation β Reduce cardiac workload β Support heart-failure management
9. π‘οΈ SAFETY ADVICE
βοΈ Prescription Medicine
Use Sacubrook V 50 mg only under appropriate medical supervision.
π« Avoid Certain Medicines
Do not use sacubitril/valsartan together with an ACE inhibitor. A required washout period is needed when switching between an ACE inhibitor and sacubitril/valsartan because of the risk of angioedema.
π Tell Your Doctor About Other Medicines
Inform your healthcare professional if you take:
ACE inhibitors
Other ARBs
Potassium supplements
Potassium-containing salt substitutes
Potassium-sparing diuretics
NSAIDs
Other blood-pressure medicines
Diuretics
π©Ί Kidney Function
Kidney function may need monitoring during treatment, particularly in patients with existing kidney problems.
π§ͺ Potassium Monitoring
Sacubitril/valsartan may increase potassium levels. Your healthcare professional may recommend blood tests.
π Blood Pressure
The medicine can lower blood pressure and may cause dizziness or light-headedness.
π€° Pregnancy
Sacubitril/valsartan should not be used during pregnancy, particularly after pregnancy is detected, because medicines affecting the renin-angiotensin system can harm the developing fetus. Contact your healthcare professional immediately if pregnancy occurs.
π€± Breastfeeding
Discuss use with your healthcare professional if breastfeeding.
π¨ Angioedema
Seek immediate medical attention for swelling of the face, lips, tongue, or throat or difficulty breathing.
π¦ Storage
Store according to the manufacturer's instructions and keep medicines out of reach of children.
10. β FREQUENTLY ASKED QUESTIONS
Q1. What is Sacubrook V 50 mg?
Sacubrook V 50 mg is a cardiovascular prescription medicine containing Sacubitril and Valsartan, an ARNI combination used in the management of certain forms of chronic heart failure.
Q2. What is Sacubrook V 50 mg used for?
It is used as part of appropriate treatment plans for certain patients with chronic heart failure.
Q3. What does ARNI mean?
ARNI stands for angiotensin receptorβneprilysin inhibitor. Sacubitril/valsartan combines neprilysin inhibition with angiotensin-II receptor blockade.
Q4. Can Sacubrook V cure heart failure?
No. It is a treatment used to manage heart failure and reduce certain cardiovascular risks; it does not permanently cure the underlying condition.
Q5. Can Sacubrook V lower blood pressure?
Yes. Lowering blood pressure is part of its pharmacological effect, but excessive blood-pressure reduction can cause dizziness or hypotension.
Q6. Can Sacubrook V affect potassium?
Yes. It can increase blood potassium levels in some patients. Your doctor may recommend blood tests to monitor potassium.
Q7. Can Sacubrook V affect kidney function?
Changes in kidney function can occur. Patients with kidney disease may require closer monitoring.
Q8. Can Sacubrook V be taken with an ACE inhibitor?
No. Sacubitril/valsartan should not be taken concurrently with an ACE inhibitor. A suitable washout period is required when switching from an ACE inhibitor.
Q9. Is Sacubrook V safe during pregnancy?
No. Sacubitril/valsartan is contraindicated during pregnancy because renin-angiotensin system blockade can cause fetal harm.
Q10. Can Sacubrook V 50 mg be supplied internationally?
International pharmaceutical supply depends on destination-country regulations, product registration, prescription status, import permissions, labeling requirements, customs procedures, and applicable laws. Buyers should verify these requirements before purchasing.
11. π SUBSTITUTE / ALTERNATIVES
The closest therapeutic alternatives depend on the patient's diagnosis, heart-failure type, kidney function, blood pressure, and current treatment regimen.
Possible alternatives include:
Other approved Sacubitril + Valsartan tablets
Other ARNI formulations
ACE inhibitors, where clinically appropriate
ARBs, where clinically appropriate
Other guideline-directed heart-failure medicines
Important: These medicines are not automatically interchangeable on a milligram-for-milligram basis. A healthcare professional should determine the appropriate medicine and dose.
12. π SEO KEYWORDS
π Primary Product Keywords
Sacubrook V 50 mg
Sacubrook V 50 mg exporter
Sacubrook V 50 mg supplier India
Sacubitril Valsartan 50 mg
Sacubitril Valsartan tablet supplier
Sacubitril Valsartan exporter India
Sacubitril Valsartan pharmaceutical supplier
Sacubitril Valsartan medicine exporter
Sacubitril Valsartan tablet exporter
Sacubitril Valsartan B2B supplier
πΌ B2B & Export Keywords
Sacubitril Valsartan supplier from India
Sacubitril Valsartan pharmaceutical exporter
Heart failure medicine exporter India
Cardiovascular medicine supplier India
Cardiology medicine exporter India
Heart failure tablets supplier
ARNI medicine supplier India
Sacubitril Valsartan wholesale supplier
Cardiovascular pharmaceutical exporter Nagpur
Pharmaceutical tablet exporter from India
π International Market Keywords
Sacubitril Valsartan supplier USA
Sacubitril Valsartan supplier UK
Sacubitril Valsartan supplier Australia
Sacubitril Valsartan supplier Canada
Sacubitril Valsartan supplier Singapore
Sacubitril Valsartan supplier South Korea
Sacubitril Valsartan supplier UAE
India pharmaceutical exporter to USA
India pharmaceutical exporter to UK
India pharmaceutical exporter to Australia
India pharmaceutical exporter to Canada
India pharmaceutical exporter to Singapore
India pharmaceutical exporter to South Korea
India pharmaceutical exporter to UAE
Nagpur pharmaceutical exporter
π₯ Long-Tail SEO Keywords
Sacubrook V 50 mg pharmaceutical exporter from India
Sacubitril Valsartan 50 mg international B2B supplier
Sacubitril Valsartan heart failure medicine supplier India
Sacubitril Valsartan cardiovascular medicine exporter
Sacubrook V 50 mg supplier from Nagpur India
Sacubitril Valsartan tablet international supply
ARNI heart failure medicine exporter India
Cardiovascular medicine B2B supplier from India
Heart failure pharmaceutical products exporter India
Sacubitril Valsartan global pharmaceutical supplier
π’ Phoenix Exim Keywords
Phoenix Exim pharmaceutical exporter
Phoenix Exim medicine exporter Nagpur
Phoenix Exim Sacubrook V supplier
Phoenix Exim cardiovascular medicine supplier
Phoenix Exim pharmaceutical supplier India
π PHOENIX EXIM β INTERNATIONAL PHARMACEUTICAL SUPPLY
Trusted Pharmaceutical Export Support from Nagpur, India
Phoenix Exim supplies pharmaceutical products for international B2B requirements, with export support for:
πΊπΈ USA | π¬π§ UK | π¦πΊ Australia | πΈπ¬ Singapore | π¨π¦ Canada | π°π· South Korea | π¦πͺ UAE
Keywords







